nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—CYP2C8—Paclitaxel—ovarian cancer	0.0342	0.167	CbGbCtD
Perphenazine—CYP2D6—Vinorelbine—ovarian cancer	0.031	0.152	CbGbCtD
Perphenazine—CYP3A4—Topotecan—ovarian cancer	0.028	0.137	CbGbCtD
Perphenazine—CYP2B6—Doxorubicin—ovarian cancer	0.0243	0.119	CbGbCtD
Perphenazine—CYP2C9—Paclitaxel—ovarian cancer	0.0238	0.117	CbGbCtD
Perphenazine—CYP3A4—Vinorelbine—ovarian cancer	0.0197	0.0966	CbGbCtD
Perphenazine—CYP3A4—Paclitaxel—ovarian cancer	0.0139	0.0679	CbGbCtD
Perphenazine—HTR7—vein—ovarian cancer	0.0132	0.0688	CbGeAlD
Perphenazine—CYP2D6—Doxorubicin—ovarian cancer	0.0118	0.0575	CbGbCtD
Perphenazine—CYP3A4—Docetaxel—ovarian cancer	0.01	0.0491	CbGbCtD
Perphenazine—CALM2—oviduct—ovarian cancer	0.00834	0.0435	CbGeAlD
Perphenazine—HTR2A—vein—ovarian cancer	0.00822	0.0429	CbGeAlD
Perphenazine—CYP3A4—Doxorubicin—ovarian cancer	0.00747	0.0366	CbGbCtD
Perphenazine—CYP2C18—uterine cervix—ovarian cancer	0.00464	0.0242	CbGeAlD
Perphenazine—AOX1—myometrium—ovarian cancer	0.00377	0.0197	CbGeAlD
Perphenazine—CALM3—myometrium—ovarian cancer	0.0034	0.0177	CbGeAlD
Perphenazine—CYP2C18—vagina—ovarian cancer	0.00314	0.0164	CbGeAlD
Perphenazine—AOX1—uterine cervix—ovarian cancer	0.00293	0.0153	CbGeAlD
Perphenazine—AOX1—decidua—ovarian cancer	0.0028	0.0146	CbGeAlD
Perphenazine—CALM2—myometrium—ovarian cancer	0.00267	0.0139	CbGeAlD
Perphenazine—CALM1—myometrium—ovarian cancer	0.00265	0.0139	CbGeAlD
Perphenazine—AOX1—endometrium—ovarian cancer	0.00265	0.0139	CbGeAlD
Perphenazine—CALM3—uterine cervix—ovarian cancer	0.00264	0.0138	CbGeAlD
Perphenazine—CALM2—embryo—ovarian cancer	0.00257	0.0134	CbGeAlD
Perphenazine—CALM1—embryo—ovarian cancer	0.00255	0.0133	CbGeAlD
Perphenazine—CALM3—decidua—ovarian cancer	0.00252	0.0132	CbGeAlD
Perphenazine—AOX1—gonad—ovarian cancer	0.00246	0.0129	CbGeAlD
Perphenazine—AOX1—uterus—ovarian cancer	0.00245	0.0128	CbGeAlD
Perphenazine—CALM3—endometrium—ovarian cancer	0.00239	0.0125	CbGeAlD
Perphenazine—CALM3—uterus—ovarian cancer	0.0022	0.0115	CbGeAlD
Perphenazine—AOX1—female reproductive system—ovarian cancer	0.0022	0.0115	CbGeAlD
Perphenazine—CALM2—epithelium—ovarian cancer	0.00209	0.0109	CbGeAlD
Perphenazine—CALM1—epithelium—ovarian cancer	0.00208	0.0109	CbGeAlD
Perphenazine—CALM2—uterine cervix—ovarian cancer	0.00208	0.0108	CbGeAlD
Perphenazine—CALM1—uterine cervix—ovarian cancer	0.00207	0.0108	CbGeAlD
Perphenazine—HTR7—epithelium—ovarian cancer	0.00204	0.0106	CbGeAlD
Perphenazine—AOX1—female gonad—ovarian cancer	0.002	0.0105	CbGeAlD
Perphenazine—AOX1—vagina—ovarian cancer	0.00199	0.0104	CbGeAlD
Perphenazine—CALM2—decidua—ovarian cancer	0.00198	0.0103	CbGeAlD
Perphenazine—CALM1—decidua—ovarian cancer	0.00197	0.0103	CbGeAlD
Perphenazine—HRH1—myometrium—ovarian cancer	0.00194	0.0101	CbGeAlD
Perphenazine—ADRA2A—myometrium—ovarian cancer	0.0019	0.00994	CbGeAlD
Perphenazine—HTR2C—female reproductive system—ovarian cancer	0.00188	0.00982	CbGeAlD
Perphenazine—CALM2—endometrium—ovarian cancer	0.00188	0.00981	CbGeAlD
Perphenazine—CALM3—bone marrow—ovarian cancer	0.00187	0.00977	CbGeAlD
Perphenazine—CALM1—endometrium—ovarian cancer	0.00187	0.00976	CbGeAlD
Perphenazine—CALM3—female gonad—ovarian cancer	0.0018	0.00941	CbGeAlD
Perphenazine—CALM3—vagina—ovarian cancer	0.00179	0.00936	CbGeAlD
Perphenazine—AOX1—testis—ovarian cancer	0.00177	0.00927	CbGeAlD
Perphenazine—CALM2—gonad—ovarian cancer	0.00174	0.0091	CbGeAlD
Perphenazine—CALM1—gonad—ovarian cancer	0.00173	0.00905	CbGeAlD
Perphenazine—CALM2—uterus—ovarian cancer	0.00173	0.00904	CbGeAlD
Perphenazine—CALM1—uterus—ovarian cancer	0.00172	0.00899	CbGeAlD
Perphenazine—HTR7—gonad—ovarian cancer	0.00169	0.00884	CbGeAlD
Perphenazine—CALM3—testis—ovarian cancer	0.0016	0.00835	CbGeAlD
Perphenazine—CYP2C8—endometrium—ovarian cancer	0.00156	0.00813	CbGeAlD
Perphenazine—HTR2A—embryo—ovarian cancer	0.00156	0.00813	CbGeAlD
Perphenazine—CALM2—female reproductive system—ovarian cancer	0.00156	0.00812	CbGeAlD
Perphenazine—CALM1—female reproductive system—ovarian cancer	0.00155	0.00809	CbGeAlD
Perphenazine—HRH1—epithelium—ovarian cancer	0.00152	0.00794	CbGeAlD
Perphenazine—HTR7—female reproductive system—ovarian cancer	0.00151	0.0079	CbGeAlD
Perphenazine—HRH1—uterine cervix—ovarian cancer	0.00151	0.00787	CbGeAlD
Perphenazine—ADRA2A—uterine cervix—ovarian cancer	0.00148	0.00773	CbGeAlD
Perphenazine—CALM2—bone marrow—ovarian cancer	0.00147	0.00767	CbGeAlD
Perphenazine—CALM1—bone marrow—ovarian cancer	0.00146	0.00763	CbGeAlD
Perphenazine—HRH1—decidua—ovarian cancer	0.00144	0.0075	CbGeAlD
Perphenazine—CALM2—female gonad—ovarian cancer	0.00141	0.00739	CbGeAlD
Perphenazine—ADRA2A—decidua—ovarian cancer	0.00141	0.00737	CbGeAlD
Perphenazine—CALM1—female gonad—ovarian cancer	0.00141	0.00736	CbGeAlD
Perphenazine—CALM2—vagina—ovarian cancer	0.00141	0.00735	CbGeAlD
Perphenazine—CALM1—vagina—ovarian cancer	0.0014	0.00731	CbGeAlD
Perphenazine—HRH1—endometrium—ovarian cancer	0.00136	0.00712	CbGeAlD
Perphenazine—ADRA2A—endometrium—ovarian cancer	0.00134	0.00699	CbGeAlD
Perphenazine—CYP2C19—vagina—ovarian cancer	0.00134	0.00698	CbGeAlD
Perphenazine—CYP2B6—gonad—ovarian cancer	0.00129	0.00676	CbGeAlD
Perphenazine—CYP2C8—female reproductive system—ovarian cancer	0.00129	0.00673	CbGeAlD
Perphenazine—AOX1—lymph node—ovarian cancer	0.00129	0.00672	CbGeAlD
Perphenazine—HTR2A—epithelium—ovarian cancer	0.00127	0.00663	CbGeAlD
Perphenazine—CALM2—testis—ovarian cancer	0.00125	0.00656	CbGeAlD
Perphenazine—CALM1—testis—ovarian cancer	0.00125	0.00653	CbGeAlD
Perphenazine—ADRA2A—gonad—ovarian cancer	0.00124	0.00649	CbGeAlD
Perphenazine—ADRA2A—uterus—ovarian cancer	0.00123	0.00644	CbGeAlD
Perphenazine—HTR7—testis—ovarian cancer	0.00122	0.00638	CbGeAlD
Perphenazine—CYP2C8—vagina—ovarian cancer	0.00117	0.00609	CbGeAlD
Perphenazine—CALM3—lymph node—ovarian cancer	0.00116	0.00605	CbGeAlD
Perphenazine—CYP2B6—female reproductive system—ovarian cancer	0.00116	0.00604	CbGeAlD
Perphenazine—DRD2—testis—ovarian cancer	0.00115	0.00603	CbGeAlD
Perphenazine—CYP2C9—female reproductive system—ovarian cancer	0.00114	0.00598	CbGeAlD
Perphenazine—HRH1—female reproductive system—ovarian cancer	0.00113	0.0059	CbGeAlD
Perphenazine—ADRA2A—female reproductive system—ovarian cancer	0.00111	0.00579	CbGeAlD
Perphenazine—HTR2A—gonad—ovarian cancer	0.00106	0.00552	CbGeAlD
Perphenazine—CYP2B6—vagina—ovarian cancer	0.00105	0.00546	CbGeAlD
Perphenazine—CYP2C8—testis—ovarian cancer	0.00104	0.00543	CbGeAlD
Perphenazine—HRH1—female gonad—ovarian cancer	0.00103	0.00537	CbGeAlD
Perphenazine—HRH1—vagina—ovarian cancer	0.00102	0.00533	CbGeAlD
Perphenazine—ADRA2A—female gonad—ovarian cancer	0.00101	0.00527	CbGeAlD
Perphenazine—ADRA2A—vagina—ovarian cancer	0.001	0.00524	CbGeAlD
Perphenazine—Liver injury—Doxorubicin—ovarian cancer	0.000955	0.00305	CcSEcCtD
Perphenazine—Lethargy—Docetaxel—ovarian cancer	0.000954	0.00304	CcSEcCtD
Perphenazine—Dysphagia—Paclitaxel—ovarian cancer	0.000953	0.00304	CcSEcCtD
Perphenazine—HTR2A—female reproductive system—ovarian cancer	0.000943	0.00493	CbGeAlD
Perphenazine—Anaphylactic shock—Topotecan—ovarian cancer	0.000942	0.00301	CcSEcCtD
Perphenazine—Infection—Topotecan—ovarian cancer	0.000936	0.00299	CcSEcCtD
Perphenazine—CYP2B6—testis—ovarian cancer	0.000933	0.00487	CbGeAlD
Perphenazine—Dyskinesia—Epirubicin—ovarian cancer	0.000924	0.00295	CcSEcCtD
Perphenazine—Anaphylactic shock—Melphalan—ovarian cancer	0.000922	0.00294	CcSEcCtD
Perphenazine—Decreased appetite—Chlorambucil—ovarian cancer	0.00092	0.00294	CcSEcCtD
Perphenazine—Dysarthria—Epirubicin—ovarian cancer	0.000918	0.00293	CcSEcCtD
Perphenazine—Infection—Melphalan—ovarian cancer	0.000916	0.00292	CcSEcCtD
Perphenazine—Amenorrhoea—Doxorubicin—ovarian cancer	0.000915	0.00292	CcSEcCtD
Perphenazine—Jaundice cholestatic—Doxorubicin—ovarian cancer	0.000915	0.00292	CcSEcCtD
Perphenazine—HRH1—testis—ovarian cancer	0.000911	0.00476	CbGeAlD
Perphenazine—CALM2—lymph node—ovarian cancer	0.00091	0.00475	CbGeAlD
Perphenazine—CALM1—lymph node—ovarian cancer	0.000905	0.00473	CbGeAlD
Perphenazine—Pancytopenia—Paclitaxel—ovarian cancer	0.000905	0.00289	CcSEcCtD
Perphenazine—Pain—Chlorambucil—ovarian cancer	0.000905	0.00289	CcSEcCtD
Perphenazine—Angioedema—Vinorelbine—ovarian cancer	0.000902	0.00288	CcSEcCtD
Perphenazine—Tachycardia—Melphalan—ovarian cancer	0.0009	0.00287	CcSEcCtD
Perphenazine—Anorexia—Topotecan—ovarian cancer	0.000898	0.00287	CcSEcCtD
Perphenazine—ADRA2A—testis—ovarian cancer	0.000895	0.00468	CbGeAlD
Perphenazine—Leukopenia—Vinorelbine—ovarian cancer	0.000884	0.00282	CcSEcCtD
Perphenazine—Anorexia—Melphalan—ovarian cancer	0.000879	0.00281	CcSEcCtD
Perphenazine—Ataxia—Docetaxel—ovarian cancer	0.000879	0.00281	CcSEcCtD
Perphenazine—CYP3A4—female reproductive system—ovarian cancer	0.000873	0.00456	CbGeAlD
Perphenazine—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.00087	0.00278	CcSEcCtD
Perphenazine—Hepatocellular injury—Epirubicin—ovarian cancer	0.000869	0.00277	CcSEcCtD
Perphenazine—Hypotension—Melphalan—ovarian cancer	0.000862	0.00275	CcSEcCtD
Perphenazine—Cough—Vinorelbine—ovarian cancer	0.000862	0.00275	CcSEcCtD
Perphenazine—Hyperglycaemia—Paclitaxel—ovarian cancer	0.00086	0.00274	CcSEcCtD
Perphenazine—CYP2D6—female reproductive system—ovarian cancer	0.000859	0.00449	CbGeAlD
Perphenazine—Abnormal dreams—Epirubicin—ovarian cancer	0.000858	0.00274	CcSEcCtD
Perphenazine—Dermatitis contact—Epirubicin—ovarian cancer	0.000858	0.00274	CcSEcCtD
Perphenazine—Dyskinesia—Doxorubicin—ovarian cancer	0.000855	0.00273	CcSEcCtD
Perphenazine—Orthostatic hypotension—Docetaxel—ovarian cancer	0.000854	0.00273	CcSEcCtD
Perphenazine—HTR2A—vagina—ovarian cancer	0.000853	0.00446	CbGeAlD
Perphenazine—Hypertension—Vinorelbine—ovarian cancer	0.000853	0.00272	CcSEcCtD
Perphenazine—Dysarthria—Doxorubicin—ovarian cancer	0.00085	0.00271	CcSEcCtD
Perphenazine—Salivary hypersecretion—Epirubicin—ovarian cancer	0.000844	0.00269	CcSEcCtD
Perphenazine—Urticaria—Chlorambucil—ovarian cancer	0.000841	0.00268	CcSEcCtD
Perphenazine—Dyspnoea—Topotecan—ovarian cancer	0.00084	0.00268	CcSEcCtD
Perphenazine—Body temperature increased—Chlorambucil—ovarian cancer	0.000837	0.00267	CcSEcCtD
Perphenazine—Dyspnoea—Melphalan—ovarian cancer	0.000822	0.00262	CcSEcCtD
Perphenazine—Decreased appetite—Topotecan—ovarian cancer	0.000819	0.00261	CcSEcCtD
Perphenazine—Dysphagia—Docetaxel—ovarian cancer	0.000808	0.00258	CcSEcCtD
Perphenazine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000806	0.00257	CcSEcCtD
Perphenazine—Pain—Topotecan—ovarian cancer	0.000806	0.00257	CcSEcCtD
Perphenazine—Constipation—Topotecan—ovarian cancer	0.000806	0.00257	CcSEcCtD
Perphenazine—Hepatocellular injury—Doxorubicin—ovarian cancer	0.000804	0.00257	CcSEcCtD
Perphenazine—Decreased appetite—Melphalan—ovarian cancer	0.000802	0.00256	CcSEcCtD
Perphenazine—Infection—Vinorelbine—ovarian cancer	0.000801	0.00256	CcSEcCtD
Perphenazine—Dermatitis contact—Doxorubicin—ovarian cancer	0.000794	0.00254	CcSEcCtD
Perphenazine—Abnormal dreams—Doxorubicin—ovarian cancer	0.000794	0.00254	CcSEcCtD
Perphenazine—Pain—Melphalan—ovarian cancer	0.000789	0.00252	CcSEcCtD
Perphenazine—Tachycardia—Vinorelbine—ovarian cancer	0.000787	0.00251	CcSEcCtD
Perphenazine—CYP2D6—female gonad—ovarian cancer	0.000782	0.00408	CbGeAlD
Perphenazine—Salivary hypersecretion—Doxorubicin—ovarian cancer	0.000781	0.00249	CcSEcCtD
Perphenazine—Hypersensitivity—Chlorambucil—ovarian cancer	0.00078	0.00249	CcSEcCtD
Perphenazine—Bradycardia—Paclitaxel—ovarian cancer	0.000777	0.00248	CcSEcCtD
Perphenazine—Anorexia—Vinorelbine—ovarian cancer	0.000768	0.00245	CcSEcCtD
Perphenazine—Pancytopenia—Docetaxel—ovarian cancer	0.000767	0.00245	CcSEcCtD
Perphenazine—HTR2A—testis—ovarian cancer	0.000761	0.00398	CbGeAlD
Perphenazine—Hypoaesthesia—Paclitaxel—ovarian cancer	0.000759	0.00242	CcSEcCtD
Perphenazine—Hypotension—Vinorelbine—ovarian cancer	0.000753	0.0024	CcSEcCtD
Perphenazine—Oedema peripheral—Paclitaxel—ovarian cancer	0.000752	0.0024	CcSEcCtD
Perphenazine—Pruritus—Chlorambucil—ovarian cancer	0.000749	0.00239	CcSEcCtD
Perphenazine—Urticaria—Topotecan—ovarian cancer	0.000748	0.00239	CcSEcCtD
Perphenazine—Body temperature increased—Topotecan—ovarian cancer	0.000745	0.00238	CcSEcCtD
Perphenazine—Urticaria—Melphalan—ovarian cancer	0.000733	0.00234	CcSEcCtD
Perphenazine—Diarrhoea—Chlorambucil—ovarian cancer	0.000724	0.00231	CcSEcCtD
Perphenazine—Dyspnoea—Vinorelbine—ovarian cancer	0.000718	0.00229	CcSEcCtD
Perphenazine—Photosensitivity—Epirubicin—ovarian cancer	0.000718	0.00229	CcSEcCtD
Perphenazine—Jaundice—Docetaxel—ovarian cancer	0.000702	0.00224	CcSEcCtD
Perphenazine—Eczema—Epirubicin—ovarian cancer	0.000702	0.00224	CcSEcCtD
Perphenazine—Decreased appetite—Vinorelbine—ovarian cancer	0.000701	0.00224	CcSEcCtD
Perphenazine—Hypersensitivity—Topotecan—ovarian cancer	0.000694	0.00222	CcSEcCtD
Perphenazine—CYP2D6—testis—ovarian cancer	0.000693	0.00362	CbGeAlD
Perphenazine—Constipation—Vinorelbine—ovarian cancer	0.000689	0.0022	CcSEcCtD
Perphenazine—Pain—Vinorelbine—ovarian cancer	0.000689	0.0022	CcSEcCtD
Perphenazine—Hypersensitivity—Melphalan—ovarian cancer	0.00068	0.00217	CcSEcCtD
Perphenazine—Agranulocytosis—Docetaxel—ovarian cancer	0.000672	0.00215	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.000668	0.00213	CcSEcCtD
Perphenazine—Pruritus—Topotecan—ovarian cancer	0.000667	0.00213	CcSEcCtD
Perphenazine—Photosensitivity—Doxorubicin—ovarian cancer	0.000664	0.00212	CcSEcCtD
Perphenazine—Erythema—Paclitaxel—ovarian cancer	0.000664	0.00212	CcSEcCtD
Perphenazine—HRH1—lymph node—ovarian cancer	0.00066	0.00345	CbGeAlD
Perphenazine—Pruritus—Melphalan—ovarian cancer	0.000653	0.00208	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.000651	0.00208	CcSEcCtD
Perphenazine—Eczema—Doxorubicin—ovarian cancer	0.000649	0.00207	CcSEcCtD
Perphenazine—ADRA2A—lymph node—ovarian cancer	0.000649	0.00339	CbGeAlD
Perphenazine—Hypoglycaemia—Epirubicin—ovarian cancer	0.000646	0.00206	CcSEcCtD
Perphenazine—Diarrhoea—Topotecan—ovarian cancer	0.000645	0.00206	CcSEcCtD
Perphenazine—Hypoaesthesia—Docetaxel—ovarian cancer	0.000643	0.00205	CcSEcCtD
Perphenazine—Lethargy—Epirubicin—ovarian cancer	0.000643	0.00205	CcSEcCtD
Perphenazine—Urticaria—Vinorelbine—ovarian cancer	0.00064	0.00204	CcSEcCtD
Perphenazine—Muscle spasms—Paclitaxel—ovarian cancer	0.000639	0.00204	CcSEcCtD
Perphenazine—Body temperature increased—Vinorelbine—ovarian cancer	0.000637	0.00203	CcSEcCtD
Perphenazine—Oedema peripheral—Docetaxel—ovarian cancer	0.000637	0.00203	CcSEcCtD
Perphenazine—Diarrhoea—Melphalan—ovarian cancer	0.000631	0.00201	CcSEcCtD
Perphenazine—Vision blurred—Paclitaxel—ovarian cancer	0.000626	0.002	CcSEcCtD
Perphenazine—Dizziness—Topotecan—ovarian cancer	0.000623	0.00199	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000618	0.00197	CcSEcCtD
Perphenazine—Agitation—Paclitaxel—ovarian cancer	0.00061	0.00195	CcSEcCtD
Perphenazine—Angioedema—Paclitaxel—ovarian cancer	0.000607	0.00194	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000603	0.00192	CcSEcCtD
Perphenazine—Cardiac arrest—Epirubicin—ovarian cancer	0.0006	0.00191	CcSEcCtD
Perphenazine—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000598	0.00191	CcSEcCtD
Perphenazine—Syncope—Paclitaxel—ovarian cancer	0.000596	0.0019	CcSEcCtD
Perphenazine—Lethargy—Doxorubicin—ovarian cancer	0.000595	0.0019	CcSEcCtD
Perphenazine—Leukopenia—Paclitaxel—ovarian cancer	0.000595	0.0019	CcSEcCtD
Perphenazine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000594	0.0019	CcSEcCtD
Perphenazine—Ataxia—Epirubicin—ovarian cancer	0.000593	0.00189	CcSEcCtD
Perphenazine—Headache—Topotecan—ovarian cancer	0.00059	0.00188	CcSEcCtD
Perphenazine—Loss of consciousness—Paclitaxel—ovarian cancer	0.000584	0.00186	CcSEcCtD
Perphenazine—Cough—Paclitaxel—ovarian cancer	0.00058	0.00185	CcSEcCtD
Perphenazine—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000576	0.00184	CcSEcCtD
Perphenazine—Convulsion—Paclitaxel—ovarian cancer	0.000575	0.00184	CcSEcCtD
Perphenazine—Hypertension—Paclitaxel—ovarian cancer	0.000573	0.00183	CcSEcCtD
Perphenazine—Pruritus—Vinorelbine—ovarian cancer	0.00057	0.00182	CcSEcCtD
Perphenazine—Erythema—Docetaxel—ovarian cancer	0.000563	0.0018	CcSEcCtD
Perphenazine—Muscular weakness—Epirubicin—ovarian cancer	0.000556	0.00177	CcSEcCtD
Perphenazine—Cardiac arrest—Doxorubicin—ovarian cancer	0.000555	0.00177	CcSEcCtD
Perphenazine—Dry mouth—Paclitaxel—ovarian cancer	0.000553	0.00177	CcSEcCtD
Perphenazine—Diarrhoea—Vinorelbine—ovarian cancer	0.000551	0.00176	CcSEcCtD
Perphenazine—Ataxia—Doxorubicin—ovarian cancer	0.000549	0.00175	CcSEcCtD
Perphenazine—Confusional state—Paclitaxel—ovarian cancer	0.000547	0.00174	CcSEcCtD
Perphenazine—Dysphagia—Epirubicin—ovarian cancer	0.000545	0.00174	CcSEcCtD
Perphenazine—Asthma—Epirubicin—ovarian cancer	0.000545	0.00174	CcSEcCtD
Perphenazine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000542	0.00173	CcSEcCtD
Perphenazine—Muscle spasms—Docetaxel—ovarian cancer	0.000541	0.00173	CcSEcCtD
Perphenazine—Eosinophilia—Epirubicin—ovarian cancer	0.00054	0.00172	CcSEcCtD
Perphenazine—Infection—Paclitaxel—ovarian cancer	0.000539	0.00172	CcSEcCtD
Perphenazine—Shock—Paclitaxel—ovarian cancer	0.000533	0.0017	CcSEcCtD
Perphenazine—Dizziness—Vinorelbine—ovarian cancer	0.000533	0.0017	CcSEcCtD
Perphenazine—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000533	0.0017	CcSEcCtD
Perphenazine—Tachycardia—Paclitaxel—ovarian cancer	0.000529	0.00169	CcSEcCtD
Perphenazine—Pancytopenia—Epirubicin—ovarian cancer	0.000518	0.00165	CcSEcCtD
Perphenazine—Anorexia—Paclitaxel—ovarian cancer	0.000517	0.00165	CcSEcCtD
Perphenazine—Muscular weakness—Doxorubicin—ovarian cancer	0.000515	0.00164	CcSEcCtD
Perphenazine—Hypotension—Paclitaxel—ovarian cancer	0.000507	0.00162	CcSEcCtD
Perphenazine—Headache—Vinorelbine—ovarian cancer	0.000505	0.00161	CcSEcCtD
Perphenazine—Syncope—Docetaxel—ovarian cancer	0.000505	0.00161	CcSEcCtD
Perphenazine—Dysphagia—Doxorubicin—ovarian cancer	0.000504	0.00161	CcSEcCtD
Perphenazine—Asthma—Doxorubicin—ovarian cancer	0.000504	0.00161	CcSEcCtD
Perphenazine—Leukopenia—Docetaxel—ovarian cancer	0.000504	0.00161	CcSEcCtD
Perphenazine—Flupentixol—ABCB1—ovarian cancer	0.000503	0.16	CrCbGaD
Perphenazine—Eosinophilia—Doxorubicin—ovarian cancer	0.000499	0.00159	CcSEcCtD
Perphenazine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000497	0.00159	CcSEcCtD
Perphenazine—Loss of consciousness—Docetaxel—ovarian cancer	0.000495	0.00158	CcSEcCtD
Perphenazine—Hyperglycaemia—Epirubicin—ovarian cancer	0.000492	0.00157	CcSEcCtD
Perphenazine—Cough—Docetaxel—ovarian cancer	0.000491	0.00157	CcSEcCtD
Perphenazine—Insomnia—Paclitaxel—ovarian cancer	0.00049	0.00156	CcSEcCtD
Perphenazine—Convulsion—Docetaxel—ovarian cancer	0.000488	0.00156	CcSEcCtD
Perphenazine—Hypertension—Docetaxel—ovarian cancer	0.000486	0.00155	CcSEcCtD
Perphenazine—Drowsiness—Epirubicin—ovarian cancer	0.000486	0.00155	CcSEcCtD
Perphenazine—Dyspnoea—Paclitaxel—ovarian cancer	0.000483	0.00154	CcSEcCtD
Perphenazine—Somnolence—Paclitaxel—ovarian cancer	0.000482	0.00154	CcSEcCtD
Perphenazine—Pancytopenia—Doxorubicin—ovarian cancer	0.000479	0.00153	CcSEcCtD
Perphenazine—Jaundice—Epirubicin—ovarian cancer	0.000474	0.00151	CcSEcCtD
Perphenazine—Decreased appetite—Paclitaxel—ovarian cancer	0.000471	0.0015	CcSEcCtD
Perphenazine—Dry mouth—Docetaxel—ovarian cancer	0.000469	0.0015	CcSEcCtD
Perphenazine—Constipation—Paclitaxel—ovarian cancer	0.000464	0.00148	CcSEcCtD
Perphenazine—Pain—Paclitaxel—ovarian cancer	0.000464	0.00148	CcSEcCtD
Perphenazine—Confusional state—Docetaxel—ovarian cancer	0.000463	0.00148	CcSEcCtD
Perphenazine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.00046	0.00147	CcSEcCtD
Perphenazine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000459	0.00147	CcSEcCtD
Perphenazine—Infection—Docetaxel—ovarian cancer	0.000456	0.00146	CcSEcCtD
Perphenazine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000455	0.00145	CcSEcCtD
Perphenazine—Agranulocytosis—Epirubicin—ovarian cancer	0.000453	0.00145	CcSEcCtD
Perphenazine—Shock—Docetaxel—ovarian cancer	0.000452	0.00144	CcSEcCtD
Perphenazine—Drowsiness—Doxorubicin—ovarian cancer	0.00045	0.00143	CcSEcCtD
Perphenazine—Tachycardia—Docetaxel—ovarian cancer	0.000448	0.00143	CcSEcCtD
Perphenazine—Bradycardia—Epirubicin—ovarian cancer	0.000444	0.00142	CcSEcCtD
Perphenazine—Jaundice—Doxorubicin—ovarian cancer	0.000438	0.0014	CcSEcCtD
Perphenazine—Anorexia—Docetaxel—ovarian cancer	0.000438	0.0014	CcSEcCtD
Perphenazine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000434	0.00139	CcSEcCtD
Perphenazine—Urticaria—Paclitaxel—ovarian cancer	0.000431	0.00137	CcSEcCtD
Perphenazine—Oedema peripheral—Epirubicin—ovarian cancer	0.00043	0.00137	CcSEcCtD
Perphenazine—Hypotension—Docetaxel—ovarian cancer	0.000429	0.00137	CcSEcCtD
Perphenazine—Body temperature increased—Paclitaxel—ovarian cancer	0.000429	0.00137	CcSEcCtD
Perphenazine—Agranulocytosis—Doxorubicin—ovarian cancer	0.00042	0.00134	CcSEcCtD
Perphenazine—Insomnia—Docetaxel—ovarian cancer	0.000416	0.00133	CcSEcCtD
Perphenazine—Bradycardia—Doxorubicin—ovarian cancer	0.000411	0.00131	CcSEcCtD
Perphenazine—Dyspnoea—Docetaxel—ovarian cancer	0.00041	0.00131	CcSEcCtD
Perphenazine—Somnolence—Docetaxel—ovarian cancer	0.000408	0.0013	CcSEcCtD
Perphenazine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000402	0.00128	CcSEcCtD
Perphenazine—Decreased appetite—Docetaxel—ovarian cancer	0.000399	0.00127	CcSEcCtD
Perphenazine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000399	0.00127	CcSEcCtD
Perphenazine—Oedema peripheral—Doxorubicin—ovarian cancer	0.000398	0.00127	CcSEcCtD
Perphenazine—Constipation—Docetaxel—ovarian cancer	0.000393	0.00125	CcSEcCtD
Perphenazine—Pain—Docetaxel—ovarian cancer	0.000393	0.00125	CcSEcCtD
Perphenazine—Pruritus—Paclitaxel—ovarian cancer	0.000384	0.00122	CcSEcCtD
Perphenazine—Erythema—Epirubicin—ovarian cancer	0.00038	0.00121	CcSEcCtD
Perphenazine—Diarrhoea—Paclitaxel—ovarian cancer	0.000371	0.00118	CcSEcCtD
Perphenazine—Muscle spasms—Epirubicin—ovarian cancer	0.000365	0.00117	CcSEcCtD
Perphenazine—Body temperature increased—Docetaxel—ovarian cancer	0.000363	0.00116	CcSEcCtD
Perphenazine—Dizziness—Paclitaxel—ovarian cancer	0.000358	0.00114	CcSEcCtD
Perphenazine—Vision blurred—Epirubicin—ovarian cancer	0.000358	0.00114	CcSEcCtD
Perphenazine—Erythema—Doxorubicin—ovarian cancer	0.000351	0.00112	CcSEcCtD
Perphenazine—Agitation—Epirubicin—ovarian cancer	0.000349	0.00111	CcSEcCtD
Perphenazine—Syncope—Epirubicin—ovarian cancer	0.000341	0.00109	CcSEcCtD
Perphenazine—Leukopenia—Epirubicin—ovarian cancer	0.00034	0.00108	CcSEcCtD
Perphenazine—Headache—Paclitaxel—ovarian cancer	0.00034	0.00108	CcSEcCtD
Perphenazine—Hypersensitivity—Docetaxel—ovarian cancer	0.000339	0.00108	CcSEcCtD
Perphenazine—Domperidone—ABCB1—ovarian cancer	0.000338	0.107	CrCbGaD
Perphenazine—Muscle spasms—Doxorubicin—ovarian cancer	0.000338	0.00108	CcSEcCtD
Perphenazine—Loss of consciousness—Epirubicin—ovarian cancer	0.000334	0.00107	CcSEcCtD
Perphenazine—Cough—Epirubicin—ovarian cancer	0.000331	0.00106	CcSEcCtD
Perphenazine—Vision blurred—Doxorubicin—ovarian cancer	0.000331	0.00106	CcSEcCtD
Perphenazine—Convulsion—Epirubicin—ovarian cancer	0.000329	0.00105	CcSEcCtD
Perphenazine—Hypertension—Epirubicin—ovarian cancer	0.000328	0.00105	CcSEcCtD
Perphenazine—Pruritus—Docetaxel—ovarian cancer	0.000325	0.00104	CcSEcCtD
Perphenazine—Agitation—Doxorubicin—ovarian cancer	0.000323	0.00103	CcSEcCtD
Perphenazine—Dry mouth—Epirubicin—ovarian cancer	0.000316	0.00101	CcSEcCtD
Perphenazine—Syncope—Doxorubicin—ovarian cancer	0.000315	0.00101	CcSEcCtD
Perphenazine—Leukopenia—Doxorubicin—ovarian cancer	0.000314	0.001	CcSEcCtD
Perphenazine—Diarrhoea—Docetaxel—ovarian cancer	0.000314	0.001	CcSEcCtD
Perphenazine—Confusional state—Epirubicin—ovarian cancer	0.000312	0.000997	CcSEcCtD
Perphenazine—Anaphylactic shock—Epirubicin—ovarian cancer	0.00031	0.000989	CcSEcCtD
Perphenazine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000309	0.000986	CcSEcCtD
Perphenazine—Infection—Epirubicin—ovarian cancer	0.000308	0.000983	CcSEcCtD
Perphenazine—Cough—Doxorubicin—ovarian cancer	0.000307	0.000979	CcSEcCtD
Perphenazine—Shock—Epirubicin—ovarian cancer	0.000305	0.000973	CcSEcCtD
Perphenazine—Convulsion—Doxorubicin—ovarian cancer	0.000304	0.000972	CcSEcCtD
Perphenazine—Dizziness—Docetaxel—ovarian cancer	0.000304	0.00097	CcSEcCtD
Perphenazine—Hypertension—Doxorubicin—ovarian cancer	0.000303	0.000968	CcSEcCtD
Perphenazine—Tachycardia—Epirubicin—ovarian cancer	0.000302	0.000965	CcSEcCtD
Perphenazine—Anorexia—Epirubicin—ovarian cancer	0.000295	0.000943	CcSEcCtD
Perphenazine—Dry mouth—Doxorubicin—ovarian cancer	0.000293	0.000934	CcSEcCtD
Perphenazine—Hypotension—Epirubicin—ovarian cancer	0.00029	0.000924	CcSEcCtD
Perphenazine—Confusional state—Doxorubicin—ovarian cancer	0.000289	0.000923	CcSEcCtD
Perphenazine—Headache—Docetaxel—ovarian cancer	0.000288	0.000919	CcSEcCtD
Perphenazine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000287	0.000915	CcSEcCtD
Perphenazine—Infection—Doxorubicin—ovarian cancer	0.000285	0.000909	CcSEcCtD
Perphenazine—Shock—Doxorubicin—ovarian cancer	0.000282	0.0009	CcSEcCtD
Perphenazine—Nefazodone—ABCB1—ovarian cancer	0.000281	0.0893	CrCbGaD
Perphenazine—Insomnia—Epirubicin—ovarian cancer	0.00028	0.000895	CcSEcCtD
Perphenazine—Tachycardia—Doxorubicin—ovarian cancer	0.00028	0.000893	CcSEcCtD
Perphenazine—Dyspnoea—Epirubicin—ovarian cancer	0.000276	0.000882	CcSEcCtD
Perphenazine—Somnolence—Epirubicin—ovarian cancer	0.000275	0.000879	CcSEcCtD
Perphenazine—Triflupromazine—ABCB1—ovarian cancer	0.000274	0.087	CrCbGaD
Perphenazine—Anorexia—Doxorubicin—ovarian cancer	0.000273	0.000872	CcSEcCtD
Perphenazine—Decreased appetite—Epirubicin—ovarian cancer	0.000269	0.00086	CcSEcCtD
Perphenazine—Hypotension—Doxorubicin—ovarian cancer	0.000268	0.000855	CcSEcCtD
Perphenazine—Constipation—Epirubicin—ovarian cancer	0.000265	0.000846	CcSEcCtD
Perphenazine—Pain—Epirubicin—ovarian cancer	0.000265	0.000846	CcSEcCtD
Perphenazine—Aripiprazole—ABCB1—ovarian cancer	0.000261	0.083	CrCbGaD
Perphenazine—Trazodone—ABCB1—ovarian cancer	0.00026	0.0826	CrCbGaD
Perphenazine—Insomnia—Doxorubicin—ovarian cancer	0.000259	0.000828	CcSEcCtD
Perphenazine—Dyspnoea—Doxorubicin—ovarian cancer	0.000256	0.000816	CcSEcCtD
Perphenazine—Somnolence—Doxorubicin—ovarian cancer	0.000255	0.000814	CcSEcCtD
Perphenazine—Decreased appetite—Doxorubicin—ovarian cancer	0.000249	0.000796	CcSEcCtD
Perphenazine—Urticaria—Epirubicin—ovarian cancer	0.000246	0.000786	CcSEcCtD
Perphenazine—Pain—Doxorubicin—ovarian cancer	0.000245	0.000783	CcSEcCtD
Perphenazine—Constipation—Doxorubicin—ovarian cancer	0.000245	0.000783	CcSEcCtD
Perphenazine—Body temperature increased—Epirubicin—ovarian cancer	0.000245	0.000782	CcSEcCtD
Perphenazine—Hypersensitivity—Epirubicin—ovarian cancer	0.000228	0.000729	CcSEcCtD
Perphenazine—Urticaria—Doxorubicin—ovarian cancer	0.000228	0.000727	CcSEcCtD
Perphenazine—Body temperature increased—Doxorubicin—ovarian cancer	0.000227	0.000723	CcSEcCtD
Perphenazine—Pruritus—Epirubicin—ovarian cancer	0.000219	0.0007	CcSEcCtD
Perphenazine—Diarrhoea—Epirubicin—ovarian cancer	0.000212	0.000677	CcSEcCtD
Perphenazine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000211	0.000674	CcSEcCtD
Perphenazine—Fluphenazine—ABCB1—ovarian cancer	0.00021	0.0669	CrCbGaD
Perphenazine—Dizziness—Epirubicin—ovarian cancer	0.000205	0.000654	CcSEcCtD
Perphenazine—Pruritus—Doxorubicin—ovarian cancer	0.000203	0.000648	CcSEcCtD
Perphenazine—Diarrhoea—Doxorubicin—ovarian cancer	0.000196	0.000626	CcSEcCtD
Perphenazine—Headache—Epirubicin—ovarian cancer	0.000194	0.00062	CcSEcCtD
Perphenazine—Clomipramine—ABCB1—ovarian cancer	0.000192	0.0612	CrCbGaD
Perphenazine—Chlorprothixene—ABCB1—ovarian cancer	0.000192	0.0609	CrCbGaD
Perphenazine—Dizziness—Doxorubicin—ovarian cancer	0.00019	0.000605	CcSEcCtD
Perphenazine—Headache—Doxorubicin—ovarian cancer	0.00018	0.000573	CcSEcCtD
Perphenazine—Promethazine—ABCB1—ovarian cancer	0.000171	0.0542	CrCbGaD
Perphenazine—Trifluoperazine—ABCB1—ovarian cancer	0.000168	0.0535	CrCbGaD
Perphenazine—Quetiapine—ABCB1—ovarian cancer	0.000163	0.0519	CrCbGaD
Perphenazine—Chlorpromazine—ABCB1—ovarian cancer	0.000132	0.042	CrCbGaD
Perphenazine—CALM3—Signaling Pathways—ERBB2—ovarian cancer	1.07e-05	3.72e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.07e-05	3.71e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CASP3—ovarian cancer	1.07e-05	3.7e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL2—ovarian cancer	1.06e-05	3.7e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—MAPK1—ovarian cancer	1.06e-05	3.68e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—EGFR—ovarian cancer	1.06e-05	3.68e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—IL6—ovarian cancer	1.06e-05	3.68e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MYC—ovarian cancer	1.06e-05	3.68e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MTOR—ovarian cancer	1.06e-05	3.67e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PIK3CB—ovarian cancer	1.06e-05	3.67e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PTEN—ovarian cancer	1.06e-05	3.67e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PTEN—ovarian cancer	1.06e-05	3.67e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—PIK3CA—ovarian cancer	1.06e-05	3.67e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—PIK3CA—ovarian cancer	1.06e-05	3.67e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MYC—ovarian cancer	1.05e-05	3.66e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—TYMS—ovarian cancer	1.05e-05	3.65e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—KRAS—ovarian cancer	1.05e-05	3.65e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—KRAS—ovarian cancer	1.05e-05	3.65e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—MYC—ovarian cancer	1.05e-05	3.64e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—MYC—ovarian cancer	1.05e-05	3.64e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.05e-05	3.64e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—PIK3CA—ovarian cancer	1.04e-05	3.63e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCND1—ovarian cancer	1.04e-05	3.6e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—ERBB2—ovarian cancer	1.04e-05	3.6e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—ERBB2—ovarian cancer	1.04e-05	3.6e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	1.04e-05	3.6e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MAPK1—ovarian cancer	1.04e-05	3.6e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—EGFR—ovarian cancer	1.04e-05	3.6e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MAPK1—ovarian cancer	1.03e-05	3.58e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—EGFR—ovarian cancer	1.03e-05	3.58e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CTNNB1—ovarian cancer	1.03e-05	3.57e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	1.03e-05	3.57e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—MAPK1—ovarian cancer	1.03e-05	3.56e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—MAPK1—ovarian cancer	1.03e-05	3.56e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—EGFR—ovarian cancer	1.03e-05	3.56e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—EGFR—ovarian cancer	1.03e-05	3.56e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CB—ovarian cancer	1.02e-05	3.55e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MTOR—ovarian cancer	1.02e-05	3.55e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CB—ovarian cancer	1.02e-05	3.55e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MTOR—ovarian cancer	1.02e-05	3.55e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CXCL8—ovarian cancer	1.02e-05	3.53e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—ovarian cancer	1.01e-05	3.51e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—VEGFA—ovarian cancer	1.01e-05	3.51e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—HRAS—ovarian cancer	1.01e-05	3.51e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MMP9—ovarian cancer	1.01e-05	3.5e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—KRAS—ovarian cancer	1e-05	3.48e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PTEN—ovarian cancer	1e-05	3.48e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—STAT3—ovarian cancer	1e-05	3.47e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	9.98e-06	3.47e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—NRAS—ovarian cancer	9.98e-06	3.47e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—PIK3CA—ovarian cancer	9.97e-06	3.46e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—VEGFA—ovarian cancer	9.94e-06	3.45e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CDKN1B—ovarian cancer	9.92e-06	3.45e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—VEGFA—ovarian cancer	9.92e-06	3.45e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—AKT1—ovarian cancer	9.92e-06	3.45e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—AKT1—ovarian cancer	9.91e-06	3.44e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—STAT3—ovarian cancer	9.84e-06	3.42e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CXCL8—ovarian cancer	9.83e-06	3.41e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CXCL8—ovarian cancer	9.83e-06	3.41e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—STAT3—ovarian cancer	9.82e-06	3.41e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—NRAS—ovarian cancer	9.82e-06	3.41e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CB—ovarian cancer	9.82e-06	3.41e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—NRAS—ovarian cancer	9.8e-06	3.4e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—KRAS—ovarian cancer	9.78e-06	3.4e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—AKT1—ovarian cancer	9.77e-06	3.39e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—HRAS—ovarian cancer	9.76e-06	3.39e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—HRAS—ovarian cancer	9.76e-06	3.39e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—KRAS—ovarian cancer	9.73e-06	3.38e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CASP3—ovarian cancer	9.72e-06	3.38e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL2—ovarian cancer	9.71e-06	3.37e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—KRAS—ovarian cancer	9.69e-06	3.37e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—KRAS—ovarian cancer	9.69e-06	3.37e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—HRAS—ovarian cancer	9.67e-06	3.36e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—IL6—ovarian cancer	9.66e-06	3.36e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—PIK3CA—ovarian cancer	9.64e-06	3.35e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—PIK3CA—ovarian cancer	9.64e-06	3.35e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CDKN1B—ovarian cancer	9.6e-06	3.33e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CDKN1B—ovarian cancer	9.6e-06	3.33e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MAPK3—ovarian cancer	9.56e-06	3.32e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTEN—ovarian cancer	9.5e-06	3.3e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCND1—ovarian cancer	9.46e-06	3.29e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CASP3—ovarian cancer	9.4e-06	3.27e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CASP3—ovarian cancer	9.4e-06	3.27e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MAPK3—ovarian cancer	9.4e-06	3.27e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL2—ovarian cancer	9.39e-06	3.26e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL2—ovarian cancer	9.39e-06	3.26e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MAPK3—ovarian cancer	9.38e-06	3.26e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CTNNB1—ovarian cancer	9.37e-06	3.26e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—IL6—ovarian cancer	9.34e-06	3.25e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—IL6—ovarian cancer	9.34e-06	3.25e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MYC—ovarian cancer	9.29e-06	3.23e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IL6—ovarian cancer	9.25e-06	3.21e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HRAS—ovarian cancer	9.22e-06	3.2e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—PIK3CA—ovarian cancer	9.2e-06	3.2e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MMP9—ovarian cancer	9.19e-06	3.19e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCND1—ovarian cancer	9.15e-06	3.18e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCND1—ovarian cancer	9.15e-06	3.18e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MYC—ovarian cancer	9.14e-06	3.18e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PTEN—ovarian cancer	9.13e-06	3.17e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MYC—ovarian cancer	9.12e-06	3.17e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MAPK1—ovarian cancer	9.09e-06	3.16e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—EGFR—ovarian cancer	9.09e-06	3.16e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CTNNB1—ovarian cancer	9.07e-06	3.15e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CTNNB1—ovarian cancer	9.07e-06	3.15e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—VEGFA—ovarian cancer	9.04e-06	3.14e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	9.03e-06	3.14e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—PIK3CA—ovarian cancer	8.99e-06	3.12e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—STAT3—ovarian cancer	8.95e-06	3.11e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	8.95e-06	3.11e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MAPK1—ovarian cancer	8.95e-06	3.11e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EGFR—ovarian cancer	8.94e-06	3.11e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—PIK3CA—ovarian cancer	8.94e-06	3.11e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NRAS—ovarian cancer	8.93e-06	3.1e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MAPK1—ovarian cancer	8.93e-06	3.1e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EGFR—ovarian cancer	8.92e-06	3.1e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HRAS—ovarian cancer	8.92e-06	3.1e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HRAS—ovarian cancer	8.92e-06	3.1e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—AKT1—ovarian cancer	8.91e-06	3.1e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—PIK3CA—ovarian cancer	8.9e-06	3.09e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—PIK3CA—ovarian cancer	8.9e-06	3.09e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MMP9—ovarian cancer	8.89e-06	3.09e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MMP9—ovarian cancer	8.89e-06	3.09e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PTEN—ovarian cancer	8.84e-06	3.07e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PTEN—ovarian cancer	8.84e-06	3.07e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL6—ovarian cancer	8.83e-06	3.07e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	8.77e-06	3.05e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—ovarian cancer	8.69e-06	3.02e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—ovarian cancer	8.65e-06	3e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—AKT1—ovarian cancer	8.62e-06	2.99e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—AKT1—ovarian cancer	8.62e-06	2.99e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—KRAS—ovarian cancer	8.59e-06	2.98e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MAPK3—ovarian cancer	8.55e-06	2.97e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL6—ovarian cancer	8.54e-06	2.97e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL6—ovarian cancer	8.54e-06	2.97e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—AKT1—ovarian cancer	8.54e-06	2.97e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—HRAS—ovarian cancer	8.51e-06	2.96e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTEN—ovarian cancer	8.48e-06	2.95e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CAV1—ovarian cancer	8.46e-06	2.94e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—KRAS—ovarian cancer	8.45e-06	2.94e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PIK3CA—ovarian cancer	8.45e-06	2.93e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—KRAS—ovarian cancer	8.43e-06	2.93e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MYC—ovarian cancer	8.32e-06	2.89e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—HRAS—ovarian cancer	8.31e-06	2.89e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—HRAS—ovarian cancer	8.27e-06	2.87e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—VEGFA—ovarian cancer	8.25e-06	2.87e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—HRAS—ovarian cancer	8.24e-06	2.86e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—HRAS—ovarian cancer	8.24e-06	2.86e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—STAT3—ovarian cancer	8.17e-06	2.84e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NRAS—ovarian cancer	8.15e-06	2.83e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—IL6—ovarian cancer	8.15e-06	2.83e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—AKT1—ovarian cancer	8.14e-06	2.83e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MAPK1—ovarian cancer	8.14e-06	2.83e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EGFR—ovarian cancer	8.14e-06	2.83e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—VEGFA—ovarian cancer	7.98e-06	2.77e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—VEGFA—ovarian cancer	7.98e-06	2.77e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IL6—ovarian cancer	7.96e-06	2.76e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PIK3CA—ovarian cancer	7.92e-06	2.75e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL6—ovarian cancer	7.92e-06	2.75e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—STAT3—ovarian cancer	7.9e-06	2.75e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—STAT3—ovarian cancer	7.9e-06	2.75e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PIK3CA—ovarian cancer	7.89e-06	2.74e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NRAS—ovarian cancer	7.88e-06	2.74e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NRAS—ovarian cancer	7.88e-06	2.74e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—IL6—ovarian cancer	7.88e-06	2.74e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—IL6—ovarian cancer	7.88e-06	2.74e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—AKT1—ovarian cancer	7.88e-06	2.74e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—AKT1—ovarian cancer	7.88e-06	2.74e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MAPK3—ovarian cancer	7.8e-06	2.71e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTEN—ovarian cancer	7.8e-06	2.71e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PIK3CA—ovarian cancer	7.76e-06	2.7e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PIK3CA—ovarian cancer	7.75e-06	2.69e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTEN—ovarian cancer	7.73e-06	2.69e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PIK3CA—ovarian cancer	7.71e-06	2.68e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	7.7e-06	2.68e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KRAS—ovarian cancer	7.69e-06	2.67e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	7.65e-06	2.66e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—ovarian cancer	7.63e-06	2.65e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MYC—ovarian cancer	7.59e-06	2.64e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MAPK3—ovarian cancer	7.55e-06	2.62e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MAPK3—ovarian cancer	7.55e-06	2.62e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—AKT1—ovarian cancer	7.52e-06	2.61e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—ovarian cancer	7.51e-06	2.61e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—ovarian cancer	7.49e-06	2.6e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PIK3CA—ovarian cancer	7.45e-06	2.59e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PIK3CA—ovarian cancer	7.45e-06	2.59e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MAPK1—ovarian cancer	7.43e-06	2.58e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EGFR—ovarian cancer	7.42e-06	2.58e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MYC—ovarian cancer	7.34e-06	2.55e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MYC—ovarian cancer	7.34e-06	2.55e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—AKT1—ovarian cancer	7.34e-06	2.55e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—AKT1—ovarian cancer	7.3e-06	2.54e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—HRAS—ovarian cancer	7.3e-06	2.54e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—AKT1—ovarian cancer	7.27e-06	2.53e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—AKT1—ovarian cancer	7.27e-06	2.53e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MAPK1—ovarian cancer	7.18e-06	2.5e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MAPK1—ovarian cancer	7.18e-06	2.5e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EGFR—ovarian cancer	7.18e-06	2.5e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EGFR—ovarian cancer	7.18e-06	2.5e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—HRAS—ovarian cancer	7.18e-06	2.5e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—HRAS—ovarian cancer	7.17e-06	2.49e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PIK3CA—ovarian cancer	7.06e-06	2.45e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KRAS—ovarian cancer	7.01e-06	2.44e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL6—ovarian cancer	6.99e-06	2.43e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—AKT1—ovarian cancer	6.9e-06	2.4e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL6—ovarian cancer	6.87e-06	2.39e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL6—ovarian cancer	6.86e-06	2.38e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—ovarian cancer	6.83e-06	2.37e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KRAS—ovarian cancer	6.78e-06	2.36e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KRAS—ovarian cancer	6.78e-06	2.36e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	6.77e-06	2.35e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PIK3CA—ovarian cancer	6.7e-06	2.33e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTEN—ovarian cancer	6.61e-06	2.3e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—HRAS—ovarian cancer	6.53e-06	2.27e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—AKT1—ovarian cancer	6.47e-06	2.25e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—AKT1—ovarian cancer	6.44e-06	2.24e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PIK3CA—ovarian cancer	6.44e-06	2.24e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—AKT1—ovarian cancer	6.34e-06	2.2e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—AKT1—ovarian cancer	6.33e-06	2.2e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—AKT1—ovarian cancer	6.3e-06	2.19e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL6—ovarian cancer	6.25e-06	2.17e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—ovarian cancer	6.23e-06	2.17e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CA—ovarian cancer	6.23e-06	2.17e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CA—ovarian cancer	6.23e-06	2.17e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—AKT1—ovarian cancer	6.09e-06	2.12e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—AKT1—ovarian cancer	6.09e-06	2.12e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—ovarian cancer	6.03e-06	2.1e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—ovarian cancer	6.03e-06	2.1e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CA—ovarian cancer	5.98e-06	2.08e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HRAS—ovarian cancer	5.96e-06	2.07e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	5.9e-06	2.05e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—AKT1—ovarian cancer	5.77e-06	2e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HRAS—ovarian cancer	5.77e-06	2e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HRAS—ovarian cancer	5.77e-06	2e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL6—ovarian cancer	5.71e-06	1.98e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL6—ovarian cancer	5.52e-06	1.92e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL6—ovarian cancer	5.52e-06	1.92e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	5.5e-06	1.91e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—AKT1—ovarian cancer	5.48e-06	1.9e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	5.46e-06	1.9e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—AKT1—ovarian cancer	5.26e-06	1.83e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTEN—ovarian cancer	5.1e-06	1.77e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—AKT1—ovarian cancer	5.09e-06	1.77e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—AKT1—ovarian cancer	5.09e-06	1.77e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—AKT1—ovarian cancer	4.89e-06	1.7e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	4.66e-06	1.62e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—AKT1—ovarian cancer	4.5e-06	1.56e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—AKT1—ovarian cancer	4.46e-06	1.55e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—AKT1—ovarian cancer	3.81e-06	1.32e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	3.6e-06	1.25e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AKT1—ovarian cancer	2.94e-06	1.02e-05	CbGpPWpGaD
